Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome

G. Goi, C. Baquero-Herrera, F. Licastro, G. Dogliotti, M. M. Corsi

Research output: Contribution to journalArticlepeer-review

Abstract

Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.

Original languageEnglish
Pages (from-to)427-429
Number of pages3
JournalInternational Journal of Cardiology
Volume113
Issue number3
DOIs
Publication statusPublished - Nov 18 2006

Keywords

  • AOPP-CRP
  • Atherosclerosis
  • Down syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome'. Together they form a unique fingerprint.

Cite this